Locally Advanced Non-resectable Breast Cancer
1 clinical trials · Condition
◉ Watch Locally Advanced Non-resectable Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer (NCT01609127) | Genta Incorporated | 2012-05-01 |
Track Locally Advanced Non-resectable Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.